The World Market for Point of Care (POC) Diagnostics

NEW YORK, Jan. 29, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

The World Market for Point of Care (POC) Diagnostics

http://www.reportlinker.com/p01080629/The-World-Market-for-Point-of-Care-POC-Diagnostics.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

Point-of-care (POC) tests are diagnostic tests that are performed at or near the site where the patient is located. They are performed in decentralized settings, outside of central hospital laboratories or centralized reference laboratories. Growth in POC testing is being fueled by many factors including the growing number of people with diabetes, the globalization of infectious diseases and the associated public health issues, advances in therapies giving physicians more tools for treatment of patients if the doctor is able to rapidly diagnose the problem, the need to monitor an ever-growing group of people with chronic diseases such as cardiovascular diseases, arthritis, cancer and other chronic conditions, and many other factors.

Point of Care Testing (POCT) is attracting considerable investor and industry activity. This Kalorama Information report, The World Market for Point of Care Diagnostics, the result of primary and secondary research into the point of care diagnostics market, presents the most current analysis of the POC Diagnostics industry and the role it plays in medical practice. This report takes an in depth look at the market, technologies, and trends in decentralized testing, looking at both self-testing by patients (also referred to as the over-the-counter (OTC) market, and at point-of-care testing by healthcare professionals.

As part of this report's coverage, the following data is included:

- Molecular POC Test Products and the Future of Molecular POC

- Self-Testing Point of Care Test Market by Category, Worldwide (Glucose, Infectious Diseases, Critical Care, Cardiac Markers, Hematology, Coagulation, Fecal Occult Blood, HbA1c, Cholesterol/Lipids, Drugs of Abuse, Pregnancy/Ovulation, Other)

- Professional Point of Care Testing Market by Test Category, Worldwide, 2011 and 2016 (Glucose, Pregnancy/Ovulation, Fecal occult blood, Coagulation, Drugs of abuse, Cholesterol, HIV, Other)

- Regional Breakout of POC Market (US, EU, Japan, ROW)

- Blood Glucose Monitoring Markets

- Small Footprint and POC Chemistry Systems

- Small Footprint and POC Hematology Systems

- Small Footprint and POC Immunoassay Systems

- Non-Invasive Testing Innovations

- Miniaturization and Microfluidics Innovations

- POC Test Revenues of Selected IVD Companies

- Selected Rapid HIV Tests on the Market

- Comparative Effectiveness, Healthcare Reform and Other Trends in IVD

- Hospital POCT, Physician Office POCT, Critical Care POCT

All countries are feeling the brunt of aging populations and an increased burden of chronic disease management. Employers and insurance companies are interested in improving the health of customers, and there are some innovative tactics developing in this area. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.

The field for rapid test devices is crowded. This report profiles 140 companies that currently market POC, plus more than 40 additional companies that are developing POC technologies and products or that have just recently entered this market. Companies profiled in this report are using a wide range of different technologies to develop and market rapid tests for much of the range of in vitro diagnostic (IVD) tests that can be performed in centralized laboratories.

The report offers a quantitative assessment of specific markets, worldwide, in U.S. dollars for 2011 to 2016. Information is provided in order to set the status quo of tests and technologies, and to get a look at what is coming. The report also discusses how these tests will affect the economics of healthcare over the near term and longer when possible.

CHAPTER ONE: EXECUTIVE SUMMARY

Size of POC Market

Trends

CHAPTER TWO: INTRODUCTION

Introduction and Definitions

Advantages and Disadvantages of Point-of-Care Testing

CHAPTER THREE: TECHNOLOGY INNOVATIONS IN POINT-OF-CARE TESTING

Miniaturization and Microfluidics Technologies

Wireless Technology

Informatics

Molecular Diagnostics

CHAPTER FOUR: LOCATIONS FOR POINT-OF-CARE TESTING

POC Testing in Hospitals and Clinics

Physicians' Office Laboratories

Retail Outlets

Other Professional POC Testing

Workplace Testing

Home Monitoring - Telemedicine

Home Self Testing

CHAPTER FIVE: POINT-OF-CARE TESTING MARKET ANALYSIS

Market Overview POC Markets – Current Markets and Market Forecasts

CHAPTER SIX: POINT-OF-CARE MARKET SEGMENTS

Diabetes Pregnancy and Ovulation

Clinical Chemistry

Urinalysis

Blood Gas

Infectious Diseases

Hematology

Coagulation

Cardiac

Drug Testing

Allergy

POC Testing Market of the Future - Molecular Diagnostics

CHAPTER SEVEN: HEALTHCARE ECONOMICS AND HEALTHCARE REFORM

Heathcare Economics and Outcomes Testing Healthcare Reform

CHAPTER EIGHT: COMPANY PROFILES – COMPANIES MARKETING POC TEST PRODUCTS

1 Step Detect Associates

3M

3test

77 Elektronika Kft.

A. Menarini Diagnostics

Abaxis, Inc.

Abbott Diagnostics

AccuBioTech Co., Ltd.

Accumetrics

Accutech

Acon Laboratories

Acrongenomics Inc.

Advanced Care Products

Advanced Microdevices Pvt. Ltd.

Aerscher Diagnostics

AgaMetrix, Inc.

Aimedics (Australia)

Akers Biomedical

Alere

Alfa Scientific Designs, Inc.

Alfa Wassermann Diagnostic Technologies, LLC

Alliance International Co., Ltd.

All Medicus

Amedica Biotech

American Bio Medica Corp

American Screening Corporation

AmeriTek

Ampcor

Analyticon Biotechnologies AG

Ani Biotech/Ani Laboratories

Apex Biotechnology Corp.

Applied Microarrays

ARJ Medical

ARKRAY, Inc.

Arlington Scientific, Inc.

Artron Laboratories

AspenBio Pharma, Inc.

Ativa Medical

Atlas Genetics

Atlas Link Biotech Co., Ltd.

Atonomics A/S

Audit Diagnostics

Autobio Diagnostics Co., Ltd.

Aventir Biotech

Axis-Shield plc

Axxin

AZOG, Inc.

B.R.A.H.M.S. AG

Bayer Diabetes Care

BD GeneOhm

Beckman Coulter Inc.

Becton, Dickinson and Company (BD)

Bestgen

BioAssay Works, LLC

Biocartis

BioHelix

Biohit HealthCare

BioLand Technology Ltd.

bioLytical Laboratories Inc.

Biomagnetics Diagnostics Corporation

Biomedix, Inc.

BioMedomics

Biomerica, Inc.

bioMerieux Inc.

Bioptik Technology, Inc

Bio-Rad Laboratories Inc.

BioScan

BioSence Medical Devices

Biosensia

BioSys Laboratories, Inc.

Biota

Biotest Medical

Blue Cross Biomedical Company

Boditech Med Inc.

BodyTel Scientific, Inc.

Boson Biotech Co., Ltd.

Branan Medical Corporation

BTNX Inc

Calypte Biomedical Corporation

Cambridge Sensors Ltd. and/or Cambridge Sensors USA

Cepheid

CERAGEM Medisys Inc.

Chematics

Chembio Diagnostic Systems, Inc.

Clarity Diagnostics

Clinical Innovations, LLC

Concateno plc

ContraVac, Inc.

CTK Biotech Inc.

DENKA SEIKEN CO., LTD.

DexCom, Inc.

DFI Co., Ltd.

Diabetech, LP

Diabetes Sentry Products Inc.

Diaglobal GmbH

Diagnostics for All (DFA)

Diagnostics for the Real World (DRW)

DiaSys Diagnostic Systems

Diazyme Laboratories

DxNA

Echo Therapeutics, Inc.

EKF-diagnostic Gmb

Elitech Group

Enigma Diagnostics Limited

Entra Health Systems

Epinex Diagnostics Laboratories, Inc.

Epocal, Inc.

EUMED Biotechnology Co. Ltd.

Fora Care

GenBio

GeneFluidics

General Biologicals Corp.

GenPrime, Inc.

GluMetrics

Heidelberger-Medical-Marketing GmbH (HMM GmbH)

Helena Laboratories USA

Hema Diagnostic Systems

HemoCue, Inc. A Quest Diagnostic Company

Hemosure

Horiba ABX S.A.

Identa Corporation

iLine Microsystems

inBios International Inc.

Innovative Biosensors, Inc.

Instrumentation Laboratory

Integrity Applications Ltd.

International Technidyne Corp (ITC)

Inverness Medical Innovations

Investigen

Ionian Technologies

IQuum, Inc.

Jant Pharmacal

LifeAssays AB

Lifescan Inc.

LifeSign LLC

Liming Bio-products Co., Ltd.

Magellan Diagnostics

Magnisense

Masimo Corporation

mBio Diagnostics

MedMira Inc.

Medtronic Inc.

Meridian Bioscience

Metaara Medical Technologies Inc

microfluidic ChipShop GmbH

Micronics Inc.

Micropoint Bioscience, Inc.

Miraculins

MP Biomedicals LLC

MycroLab Pty Ltd.

Nanomix, Inc.

Nanosphere, Inc.

Network Biosystems, Inc. (NetBio)

Nexus Dx, Inc. (Subsidiary of Samsung Electronics Co.)

Nipro Diagnostics

Noninvasive Medical Technologies, Inc.

Nova Biomedical

OPKU Health

OPTI Medical Systems, Inc.

OraSure Technologies, Inc.

Orion Diagnostica

OrSense Ltd.

Ortho Clinical Diagnostics

Oxonica Diagnostics

Pepex Biomedical

pes diagnosesysteme GmbH

PlaCor, Inc.

PointCare Technologies

Polymedco, Inc.

Polymer Technology Systems, Inc.

Princeton Biomeditech Corp

Probe Scientific Ltd

Prodigy Diabetes Care

Propper Manufacturing Co.

Qiagen N.V.

QuantuMDx Group

Quidel Corporation

QuikTest USA, Inc.

Quotient Diagnostics

Radiometer A/S

Rapid Pathogen Screening

ReLIA Diagnostic Systems

Rennesens GmbH

Response Biomedical Corp.

Rheonix, Inc.

Roche Diagnostics

SAKAE Corporation

Savyon Diagnostics

Sekisui Diagnostics

Siemens Healthcare Diagnostics

Sysmex Corporation

Thermo Scientific

Zonda, Inc.

Selected Tables

POC Sales by Test Category, Worldwide

World Glucose Monitoring Sales by Company

Selected Continuous Blood Glucose Monitoring Systems

Selected OTC Pregnancy and Ovulation Tests

Selected POC Clinical Chemistry Systems

Selected Urinalysis POC Tests

Selected POC Blood Gas Systems

Selected Rapid Infectious Disease Tests

Selected POC Coagulation Tests

Selected Molecular Diagnostic Companies Targeting Rapid or POC Market

To order this report:

: The World Market for Point of Care (POC) Diagnostics

Contact Nicolas: nicolasbombourg@reportlinker.com
US: (805)-652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.